Deepen Disease Insights with Body Composition Analysis
AMRA is at the forefront of medical imaging, with the ability to deliver anatomically accurate and precise fat and muscle measurements providing body composition insights powered by patented, regulatory compliant, MRI software and bioinformatics.
50 +
Individual Muscles, Adipose Tissue and Organs Volumetrically Measured
500 +
Imaging Sites Certified with AMRA’s MRI Protocol
55,000 +
Quality-controlled Data Sets in the Body Composition Database
Use Easy-to-Integrate MRI-Based Services for
Clinical Services
Medical Imaging for Clinical Care
Seamless, patient-friendly, and cost-effective—you send us MR images; we return precise, actionable individualized body composition insights.
Research Services
Medical Research & Clinical Trials
Unlock breakthroughs and advance your clinical trials by collaborating with our team of whole-body MRI experts.
Showcasing The Transformative Potential of Our Unique Fat & Muscle Z-Score Biomarkers
AMRA Headlines Major Conferences to Close 2024. As an eventful 2024 comes to a close, AMRA is excited for one last road trip this year, as we embark on a journey to share more about how our MRI-based approaches are transforming research in metabolic diseases and their treatments.
Maximize and Accelerate Success with our Technology and Team of MRI Experts
You need a reliable partner that understands your science, your workflow, and your needs. Whether you are designing your first clinical trial or are using MRI in clinical practice, you can elevate your team with AMRA’s skilled MRI experts.
Get the body composition data and services you need so you can focus on what matters most: your patients, your science, and your clinical decisions.
Experience the Future of Medical Imaging
AMRA is revolutionizing medical imaging with our digital health platform, which segments and quantifies fat and muscle measurements for both clinical and research use. Our protocol is standardized across the major 1.5T and 3T MRI platforms and facilitates quick processing and turnaround of body composition insights.
Latest News
Decoding Duchenne Muscular Dystrophy: MRI Study Explores the Relationship Between AMRA’s Muscle Biomarkers and Functional Changes in Individuals with DMD
Recent AMRA research examines whether the use of MRI-based biomarkers as surrogate endpoints in DMD clinical trials is feasible, allowing for more informative descriptions of disease severity and progression in DMD
AMRA at MDA 2025 – Presents research from one of the largest natural history studies to date, validating our unique, MRI-based biomarkers for use as endpoints in upcoming FSHD trials
LINKÖPING, Sweden, March 14, 2025 – AMRA Medical is muscling up for the 2025 Muscular Dystrophy Association’s Clinical and Scientific Conference (MDA…
Upcoming Events
ECO
- May 11, 2025 – May 14, 2025
- Malaga Spain
Gastrodagarna
- May 14, 2025 – May 16, 2025
- Stockholm, Sweden
International Research Congress on FSHD
- June 12, 2025 – June 13, 2025
- Amsterdam, NL